Zestra Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Zestra General Information
Description
Provider of oil bottles and products intended for women for sexual arousal. The company's products are formulated with botanical oils, free of synthetics, hormones, and parabens, enabling women to increase their sexual satisfaction and allowing their bodies to feel more pleasure.
Contact Information
Website
www.zestra.com(Operating Subsidiary)
Corporate Office
- 228 Park Avenue South
- Suite 300
- New York, NY 10003
- United States
Corporate Office
- 228 Park Avenue South
- Suite 300
- New York, NY 10003
- United States
Zestra Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 30-Dec-2013 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A1) | 20-Dec-2010 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 04-Oct-2010 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 03-Feb-2010 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2009 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 24-Sep-2008 | $8.5M | $14.5M | Completed | Generating Revenue | |
| 1. Later Stage VC | 23-Aug-2006 | $6M | $6M | Completed | Generating Revenue |
Zestra Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
Zestra Patents
Zestra Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20040202739-A1 | Borage seed oil and angelica pubescens root; topical | Active | 27-Jun-2000 | ||
| US-7875299-B2 | Borage seed oil and angelica pubescens root; topical | Inactive | 27-Jun-2000 | ||
| US-20020034557-A1 | Borage seed oil, angelica pubescens root, coleus forskohlii extract, vinpocetine, ferulic acid, magnesium, ascorbyl palmitate, capric/caprylic triglyceride, and silica; topical | Active | 27-Jun-2000 | ||
| US-6737084-B2 | Borage seed oil, angelica pubescens root, coleus forskohlii extract, vinpocetine, ferulic acid, magnesium, ascorbyl palmitate, capric/caprylic triglyceride, and silica; topical | Inactive | 27-Jun-2000 | ||
| US-20110117228-A1 | Compositions and methods for enhancing and treating female sexual response | Active | 27-Jun-2000 | A61K36/232 |
Zestra Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Big Red Ventures | Venture Capital | Minority | ||
| Canterbury Capital (South Carolina) | Venture Capital | Minority | ||
| Quaker Partners | Venture Capital | Minority | ||
| Roxiticus Ventures | Venture Capital | Minority | ||
| Springboard Enterprises | Accelerator/Incubator | Minority |
Zestra FAQs
-
When was Zestra founded?
Zestra was founded in 1996.
-
Where is Zestra headquartered?
Zestra is headquartered in New York, NY.
-
What industry is Zestra in?
Zestra’s primary industry is Personal Products.
-
Is Zestra a private or public company?
Zestra is a Private company.
-
What is Zestra’s current revenue?
The current revenue for Zestra is .
-
How much funding has Zestra raised over time?
Zestra has raised $22.7M.
-
Who are Zestra’s investors?
Big Red Ventures, Canterbury Capital (South Carolina), Quaker Partners, Roxiticus Ventures, and Springboard Enterprises are 5 of 6 investors who have invested in Zestra.
-
When was Zestra acquired?
Zestra was acquired on 30-Dec-2013.
-
Who acquired Zestra?
Zestra was acquired by Innovus Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process